Literature DB >> 31924656

Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype.

Léa Paolini1, Clément Adam1, Yves Delneste1,2, Pascale Jeannin3,2, Céline Beauvillain1,2, Laurence Preisser1, Simon Blanchard1,2, Pascale Pignon1, Valérie Seegers1,4, Louise-Marie Chevalier1,4, Mario Campone1,4, Romuald Wernert4, Véronique Verrielle4, Pedro Raro4, Norbert Ifrah1,5, Vincent Lavoué6,7, Philippe Descamps8, Alain Morel1,4, Véronique Catros9, Guillaume Tcherkez10, Guy Lenaers11, Cinzia Bocca11, Judith Kouassi Nzoughet11, Vincent Procaccio11,12.   

Abstract

In established tumors, tumor-associated macrophages (TAM) orchestrate nonresolving cancer-related inflammation and produce mediators favoring tumor growth, metastasis, and angiogenesis. However, the factors conferring inflammatory and protumor properties on human macrophages remain largely unknown. Most solid tumors have high lactate content. We therefore analyzed the impact of lactate on human monocyte differentiation. We report that prolonged lactic acidosis induces the differentiation of monocytes into macrophages with a phenotype including protumor and inflammatory characteristics. These cells produce tumor growth factors, inflammatory cytokines, and chemokines as well as low amounts of IL10. These effects of lactate require its metabolism and are associated with hypoxia-inducible factor-1α stabilization. The expression of some lactate-induced genes is dependent on autocrine M-CSF consumption. Finally, TAMs with protumor and inflammatory characteristics (VEGFhigh CXCL8+ IL1β+) are found in solid ovarian tumors. These results show that tumor-derived lactate links the protumor features of TAMs with their inflammatory properties. Treatments that reduce tumor glycolysis or tumor-associated acidosis may help combat cancer. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 31924656     DOI: 10.1158/2326-6066.CIR-18-0749

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  14 in total

Review 1.  Hypoxia as a Modulator of Inflammation and Immune Response in Cancer.

Authors:  Rosa A Castillo-Rodríguez; Cristina Trejo-Solís; Alfredo Cabrera-Cano; Saúl Gómez-Manzo; Víctor Manuel Dávila-Borja
Journal:  Cancers (Basel)       Date:  2022-05-04       Impact factor: 6.575

Review 2.  Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies.

Authors:  Gabriel Osborn; Chara Stavraka; Rebecca Adams; Ahmad Sayasneh; Sharmistha Ghosh; Ana Montes; Katie E Lacy; Rebecca Kristeleit; James Spicer; Debra H Josephs; James N Arnold; Sophia N Karagiannis
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

3.  Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.

Authors:  Wenhui Li; Ming Xu; Yu Li; Ziwei Huang; Jun Zhou; Qiuyang Zhao; Kehao Le; Fang Dong; Cheng Wan; Pengfei Yi
Journal:  J Transl Med       Date:  2020-02-18       Impact factor: 5.531

Review 4.  COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

Authors:  Antonio Macciò; Sara Oppi; Clelia Madeddu
Journal:  J Ovarian Res       Date:  2021-02-08       Impact factor: 4.234

5.  Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma.

Authors:  Shanshan Yu; Luya Cai; Chuan Liu; Ruihong Gu; Lingyi Cai; Leying Zhuo
Journal:  Mol Med       Date:  2021-04-08       Impact factor: 6.354

Review 6.  What do cellular responses to acidity tell us about cancer?

Authors:  Wiktoria Blaszczak; Pawel Swietach
Journal:  Cancer Metastasis Rev       Date:  2021-11-30       Impact factor: 9.264

Review 7.  Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Authors:  Ya-Nan Pi; Wen-Cai Qi; Bai-Rong Xia; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 8.786

Review 8.  The updated landscape of tumor microenvironment and drug repurposing.

Authors:  Ming-Zhu Jin; Wei-Lin Jin
Journal:  Signal Transduct Target Ther       Date:  2020-08-25

Review 9.  Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment.

Authors:  Zicong He; Shuixing Zhang
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

10.  Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells.

Authors:  Audrey Wetzel; Francis Bonnefoy; Cécile Chagué; Mathieu Vetter; Mélanie Couturier; Blandine Baffert; Olivier Adotévi; Philippe Saas; Sylvain Perruche
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.